40 results
8-K/A
EX-10.1
ARAV
Aravive Inc
28 Oct 22
Other Events
4:05pm
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale
8-K
EX-10.1
ARAV
Aravive Inc
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale
8-K
EX-10.2
ARAV
Aravive Inc
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any
8-K
EX-10.1
ARAV
Aravive Inc
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval
8-K
EX-10.1
93lj7tkj15y0o qe
16 Feb 21
Entry into a Material Definitive Agreement
7:10am
8-K
EX-10.1
zdx1ca dey
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
8-K
EX-1.1
5uw8 g9w1pnd54gm2
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
8-K
EX-1.1
6o7m065d7
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
S-4
EX-10.6
v0wkqg845h63wte
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm
S-4
wgssa8ollstx3rmi0
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm